Sign In
Buy LH
$258.92
+1.22 (+0.473%)
At Close: Jun 03, 2026
Labcorp Holdings Inc. (LH) Q4 2025 Earnings Call Transcript
04:15pm, Tuesday, 17'th Feb 2026
Labcorp Holdings Inc. (LH) Q4 2025 Earnings Call Transcript
Labcorp Q4 Earnings Beat, Revenues Miss, Stock Down in Pre-Market
11:10am, Tuesday, 17'th Feb 2026
LH beats Q4 EPS estimates with 18% growth, but a revenue miss and cautious investor reaction push shares lower in pre-market trading.
Labcorp (LH) Q4 Earnings: Taking a Look at Key Metrics Versus Estimates
10:31am, Tuesday, 17'th Feb 2026
While the top- and bottom-line numbers for Labcorp (LH) give a sense of how the business performed in the quarter ended December 2025, it could be worth looking at how some of its key metrics compare
Labcorp Holdings (LH) Q4 Earnings Surpass Estimates
09:01am, Tuesday, 17'th Feb 2026
Labcorp Holdings (LH) came out with quarterly earnings of $4.07 per share, beating the Zacks Consensus Estimate of $3.95 per share. This compares to earnings of $3.45 per share a year ago.
Labcorp Announces 2025 Fourth Quarter and Full Year Results
06:50am, Tuesday, 17'th Feb 2026
Company Provides 2026 Guidance Financial results from Operations versus 2024: Revenue: Q4 of $3.52 billion vs $3.33 billion; Full year of $13.95 billion vs $13.01 billion Diluted EPS: Q4 of $1.98 vs $
Adam Schechter Sells 5,273 Shares of Labcorp (NYSE:LH) Stock
04:54am, Sunday, 15'th Feb 2026
Labcorp Holdings Inc. (NYSE: LH - Get Free Report) CEO Adam Schechter sold 5,273 shares of the business's stock in a transaction that occurred on Wednesday, February 11th. The stock was sold at an ave
Will Labcorp (LH) Beat Estimates Again in Its Next Earnings Report?
01:10pm, Wednesday, 11'th Feb 2026
Labcorp (LH) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
Stay Ahead of the Game With Labcorp (LH) Q4 Earnings: Wall Street's Insights on Key Metrics
10:16am, Wednesday, 11'th Feb 2026
Besides Wall Street's top-and-bottom-line estimates for Labcorp (LH), review projections for some of its key metrics to gain a deeper understanding of how the company might have fared during the quart
Labcorp Launches First FDA-Cleared Blood Test for Alzheimer's Disease Assessment in Primary Care
07:00am, Wednesday, 11'th Feb 2026
Elecsys ® pTau-181 test helps clinicians rule out Alzheimer's disease by identifying patients unlikely to have amyloid pathology Now available nationwide in primary care settings for patients aged 5
Labcorp Holdings Inc. $LH Stake Lessened by Jensen Investment Management Inc.
03:36am, Wednesday, 11'th Feb 2026
Jensen Investment Management Inc. decreased its holdings in Labcorp Holdings Inc. (NYSE: LH) by 8.0% during the third quarter, according to its most recent filing with the Securities and Exchange Comm
Labcorp's Q4 Earnings Preview: What's in Store for the Stock?
10:01am, Tuesday, 10'th Feb 2026
LH heads into its Q4 earnings report with rising revenue and EPS expectations, driven by Diagnostics momentum, acquisitions and expanding test demand.
Labcorp Appoints John H. Sampson, M.D.
08:30am, Monday, 09'th Feb 2026
BURLINGTON, N.C., Feb. 9, 2026 /PRNewswire/ -- Labcorp (NYSE: LH), a global leader of innovative and comprehensive laboratory services, today announced the appointment of John H.
Envestnet Asset Management Inc. Sells 15,188 Shares of Labcorp Holdings Inc. $LH
03:06am, Monday, 09'th Feb 2026
Envestnet Asset Management Inc. decreased its holdings in Labcorp Holdings Inc. (NYSE: LH) by 5.5% in the third quarter, according to its most recent disclosure with the Securities and Exchange Commis
Labcorp Holdings Inc. $LH Shares Bought by New York State Common Retirement Fund
03:12am, Tuesday, 03'rd Feb 2026
New York State Common Retirement Fund increased its holdings in Labcorp Holdings Inc. (NYSE: LH) by 12.0% during the undefined quarter, according to the company in its most recent 13F filing with the
Labcorp Holdings Inc. $LH Stake Reduced by Cambiar Investors LLC
05:58am, Wednesday, 28'th Jan 2026
Cambiar Investors LLC cut its holdings in shares of Labcorp Holdings Inc. (NYSE: LH) by 21.9% in the third quarter, according to the company in its most recent filing with the Securities and Exchange
